Video Display CEO Buys 5.7K Shares and 4 Insider Buys to Note
January 24, 2013
Baker Mark Robert who is CEO at Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), bought 1,215 shares at $2.82 per share for a total value of $3,429. The shares recently traded at $2.94, up $0.12, or 4.26% since the insider buy.
Current Price $2.94
Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
